The Hong Kong Polytechnic University (PolyU) has joined hands with Tianjin Medical University (TMU), China to nurture ta...
Lung cancer remains the most common cancer in Hong Kong. As a leading cancer killer worldwide, its treatment still needs...
Researchers in Asia are increasingly evaluating the significance and scope of proteomics in biomolecular discovery effor...
A team of researchers from the National University of Singapore (NUS) led by Assistant Professor Cheow Lih Feng from the...
Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-M...
Scientists at Duke-NUS Medical School, A*STAR’s Genome Institute of Singapore (GIS), Singapore General Hospital (S...
The Hong Kong Science and Technology Parks Corporation (HKSTP, a public corporation set up by the Hong Kong Government) ...
Cyteph, a spin-out biotechnology company from QIMR Berghofer Medical Research Institute in Australia, has been awa...
South Korean firms HanAll Biopharma and Daewoong Pharmaceutical have entered into a co-development agreement with N...
In a modern take on the Victorian gold rush, a Monash University-led project is successfully ‘bioprospecting&rsquo...
The Chinese University of Hong Kong’s (CUHK) Faculty of Medicine (CU Medicine) led a team of a dozen international...
Singapore based startup CytoMed Therapeutics, spun off from the Agency for Science, Technology and Research (A*STAR), ha...
Shanghai Junshi Biosciences Co. has collaborated with Indian pharmaceutical firm Dr. Reddy’s Laboratories to devel...
A ground-breaking clinical trial involving microbiome transfer to alleviate gut problems in Autistic people is starting ...
A Hong Kong Baptist University (HKBU) collaborative research team has shown that urine tests for human cytomegalovirus (...
Can you explain what GPCR heteromers are and why they are a promising target for cancer therapeutics? Before I answer y...
A key goal for any innovative cancer treatment is the ability to deliver an anti-cancer agent directly to the tumour and...
MicrofluidX, a UK-based provider of next generation bioreactors for cell biology research and cell therapy manufac...
